Global Blood & Tissue DNA Kit Market Growth 2026-2032
The global Blood & Tissue DNA Kit market size is predicted to grow from US$ 307 million in 2025 to US$ 484 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.
In 2025, global Blood & Tissue DNA Kits approximately 3697 k units, with an average global market price of around US$ 85 per unit. Gross margin is about 48%. The cost is 44 usd. The Production is about 4200 k units. Blood & Tissue DNA Kit is a sample preparation reagent system used to isolate and purify high-quality genomic DNA from blood and tissue specimens through cell lysis, protein digestion, and DNA binding and elution processes. Upstream, it relies on lysis buffers, enzymes, spin columns or magnetic beads, and consumable plastics. Downstream, it serves as a fundamental input for PCR, qPCR, NGS library preparation, genotyping, and molecular diagnostics, and is widely used by clinical laboratories, research institutes, biotech companies, and diagnostic kit manufacturers as a core tool in molecular biology workflows.
United States market for Blood & Tissue DNA Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Blood & Tissue DNA Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Blood & Tissue DNA Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Blood & Tissue DNA Kit players cover QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Blood & Tissue DNA Kit Industry Forecast” looks at past sales and reviews total world Blood & Tissue DNA Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood & Tissue DNA Kit sales for 2026 through 2032. With Blood & Tissue DNA Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood & Tissue DNA Kit industry.
This Insight Report provides a comprehensive analysis of the global Blood & Tissue DNA Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood & Tissue DNA Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood & Tissue DNA Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood & Tissue DNA Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood & Tissue DNA Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood & Tissue DNA Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Blood & Tissue DNA Kit market?
What factors are driving Blood & Tissue DNA Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood & Tissue DNA Kit market opportunities vary by end market size?
How does Blood & Tissue DNA Kit break out by Type, by Application?
In 2025, global Blood & Tissue DNA Kits approximately 3697 k units, with an average global market price of around US$ 85 per unit. Gross margin is about 48%. The cost is 44 usd. The Production is about 4200 k units. Blood & Tissue DNA Kit is a sample preparation reagent system used to isolate and purify high-quality genomic DNA from blood and tissue specimens through cell lysis, protein digestion, and DNA binding and elution processes. Upstream, it relies on lysis buffers, enzymes, spin columns or magnetic beads, and consumable plastics. Downstream, it serves as a fundamental input for PCR, qPCR, NGS library preparation, genotyping, and molecular diagnostics, and is widely used by clinical laboratories, research institutes, biotech companies, and diagnostic kit manufacturers as a core tool in molecular biology workflows.
United States market for Blood & Tissue DNA Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Blood & Tissue DNA Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Blood & Tissue DNA Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Blood & Tissue DNA Kit players cover QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Blood & Tissue DNA Kit Industry Forecast” looks at past sales and reviews total world Blood & Tissue DNA Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood & Tissue DNA Kit sales for 2026 through 2032. With Blood & Tissue DNA Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood & Tissue DNA Kit industry.
This Insight Report provides a comprehensive analysis of the global Blood & Tissue DNA Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood & Tissue DNA Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood & Tissue DNA Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood & Tissue DNA Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood & Tissue DNA Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood & Tissue DNA Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Whole Blood
- Plasma or Serum
- Buffy Coat
- Spin Column-based DNA Kit
- Magnetic Bead-based DNA Kit
- Precipitation-based DNA Kit
- R&D Organisations
- Biotechnology Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- QIAGEN
- Thermo Fisher Scientific
- Sigma-Aldrich (Merck)
- Roche
- Axygen (Corning)
- Analytik Jena
- Promega
- Zymo Research
- Illumina
- Macherey-Nagel
- Bio-Rad
- Omega Bio-tek
- Geneaid
- Lucigen (Biosearch Technologies)
- Norgen
- MGI Tech Co., Ltd.
- BioVision
What is the 10-year outlook for the global Blood & Tissue DNA Kit market?
What factors are driving Blood & Tissue DNA Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood & Tissue DNA Kit market opportunities vary by end market size?
How does Blood & Tissue DNA Kit break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood & Tissue DNA Kit Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood & Tissue DNA Kit by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood & Tissue DNA Kit by Country/Region, 2021, 2025 & 2032
2.2 Blood & Tissue DNA Kit Segment by Type
2.2.1 Whole Blood
2.2.2 Plasma or Serum
2.2.3 Buffy Coat
2.2.4 Blood & Tissue DNA Kit Sales by Type
2.2.4.1 Global Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
2.2.4.2 Global Blood & Tissue DNA Kit Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Blood & Tissue DNA Kit Sale Price by Type (2021-2026)
2.3 Blood & Tissue DNA Kit Segment by Technology
2.3.1 Spin Column-based DNA Kit
2.3.2 Magnetic Bead-based DNA Kit
2.3.3 Precipitation-based DNA Kit
2.3.4 Blood & Tissue DNA Kit Sales by Technology
2.3.4.1 Global Blood & Tissue DNA Kit Sales Market Share by Technology (2021-2026)
2.3.4.2 Global Blood & Tissue DNA Kit Revenue and Market Share by Technology (2021-2026)
2.3.4.3 Global Blood & Tissue DNA Kit Sale Price by Technology (2021-2026)
2.4 Blood & Tissue DNA Kit Segment by Application
2.4.1 R&D Organisations
2.4.2 Biotechnology Companies
2.4.3 Blood & Tissue DNA Kit Sales by Application
2.4.3.1 Global Blood & Tissue DNA Kit Sale Market Share by Application (2021-2026)
2.4.3.2 Global Blood & Tissue DNA Kit Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Blood & Tissue DNA Kit Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood & Tissue DNA Kit Breakdown Data by Company
3.1.1 Global Blood & Tissue DNA Kit Annual Sales by Company (2021-2026)
3.1.2 Global Blood & Tissue DNA Kit Sales Market Share by Company (2021-2026)
3.2 Global Blood & Tissue DNA Kit Annual Revenue by Company (2021-2026)
3.2.1 Global Blood & Tissue DNA Kit Revenue by Company (2021-2026)
3.2.2 Global Blood & Tissue DNA Kit Revenue Market Share by Company (2021-2026)
3.3 Global Blood & Tissue DNA Kit Sale Price by Company
3.4 Key Manufacturers Blood & Tissue DNA Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood & Tissue DNA Kit Product Location Distribution
3.4.2 Players Blood & Tissue DNA Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD & TISSUE DNA KIT BY GEOGRAPHIC REGION
4.1 World Historic Blood & Tissue DNA Kit Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood & Tissue DNA Kit Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood & Tissue DNA Kit Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood & Tissue DNA Kit Market Size by Country/Region (2021-2026)
4.2.1 Global Blood & Tissue DNA Kit Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood & Tissue DNA Kit Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood & Tissue DNA Kit Sales Growth
4.4 APAC Blood & Tissue DNA Kit Sales Growth
4.5 Europe Blood & Tissue DNA Kit Sales Growth
4.6 Middle East & Africa Blood & Tissue DNA Kit Sales Growth
5 AMERICAS
5.1 Americas Blood & Tissue DNA Kit Sales by Country
5.1.1 Americas Blood & Tissue DNA Kit Sales by Country (2021-2026)
5.1.2 Americas Blood & Tissue DNA Kit Revenue by Country (2021-2026)
5.2 Americas Blood & Tissue DNA Kit Sales by Type (2021-2026)
5.3 Americas Blood & Tissue DNA Kit Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood & Tissue DNA Kit Sales by Region
6.1.1 APAC Blood & Tissue DNA Kit Sales by Region (2021-2026)
6.1.2 APAC Blood & Tissue DNA Kit Revenue by Region (2021-2026)
6.2 APAC Blood & Tissue DNA Kit Sales by Type (2021-2026)
6.3 APAC Blood & Tissue DNA Kit Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood & Tissue DNA Kit by Country
7.1.1 Europe Blood & Tissue DNA Kit Sales by Country (2021-2026)
7.1.2 Europe Blood & Tissue DNA Kit Revenue by Country (2021-2026)
7.2 Europe Blood & Tissue DNA Kit Sales by Type (2021-2026)
7.3 Europe Blood & Tissue DNA Kit Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood & Tissue DNA Kit by Country
8.1.1 Middle East & Africa Blood & Tissue DNA Kit Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood & Tissue DNA Kit Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood & Tissue DNA Kit Sales by Type (2021-2026)
8.3 Middle East & Africa Blood & Tissue DNA Kit Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood & Tissue DNA Kit
10.3 Manufacturing Process Analysis of Blood & Tissue DNA Kit
10.4 Industry Chain Structure of Blood & Tissue DNA Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood & Tissue DNA Kit Distributors
11.3 Blood & Tissue DNA Kit Customer
12 WORLD FORECAST REVIEW FOR BLOOD & TISSUE DNA KIT BY GEOGRAPHIC REGION
12.1 Global Blood & Tissue DNA Kit Market Size Forecast by Region
12.1.1 Global Blood & Tissue DNA Kit Forecast by Region (2027-2032)
12.1.2 Global Blood & Tissue DNA Kit Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood & Tissue DNA Kit Forecast by Type (2027-2032)
12.7 Global Blood & Tissue DNA Kit Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 QIAGEN
13.1.1 QIAGEN Company Information
13.1.2 QIAGEN Blood & Tissue DNA Kit Product Portfolios and Specifications
13.1.3 QIAGEN Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 QIAGEN Main Business Overview
13.1.5 QIAGEN Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Blood & Tissue DNA Kit Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Sigma-Aldrich (Merck)
13.3.1 Sigma-Aldrich (Merck) Company Information
13.3.2 Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Product Portfolios and Specifications
13.3.3 Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sigma-Aldrich (Merck) Main Business Overview
13.3.5 Sigma-Aldrich (Merck) Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Blood & Tissue DNA Kit Product Portfolios and Specifications
13.4.3 Roche Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Axygen (Corning)
13.5.1 Axygen (Corning) Company Information
13.5.2 Axygen (Corning) Blood & Tissue DNA Kit Product Portfolios and Specifications
13.5.3 Axygen (Corning) Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Axygen (Corning) Main Business Overview
13.5.5 Axygen (Corning) Latest Developments
13.6 Analytik Jena
13.6.1 Analytik Jena Company Information
13.6.2 Analytik Jena Blood & Tissue DNA Kit Product Portfolios and Specifications
13.6.3 Analytik Jena Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Analytik Jena Main Business Overview
13.6.5 Analytik Jena Latest Developments
13.7 Promega
13.7.1 Promega Company Information
13.7.2 Promega Blood & Tissue DNA Kit Product Portfolios and Specifications
13.7.3 Promega Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Promega Main Business Overview
13.7.5 Promega Latest Developments
13.8 Zymo Research
13.8.1 Zymo Research Company Information
13.8.2 Zymo Research Blood & Tissue DNA Kit Product Portfolios and Specifications
13.8.3 Zymo Research Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zymo Research Main Business Overview
13.8.5 Zymo Research Latest Developments
13.9 Illumina
13.9.1 Illumina Company Information
13.9.2 Illumina Blood & Tissue DNA Kit Product Portfolios and Specifications
13.9.3 Illumina Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Illumina Main Business Overview
13.9.5 Illumina Latest Developments
13.10 Macherey-Nagel
13.10.1 Macherey-Nagel Company Information
13.10.2 Macherey-Nagel Blood & Tissue DNA Kit Product Portfolios and Specifications
13.10.3 Macherey-Nagel Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Macherey-Nagel Main Business Overview
13.10.5 Macherey-Nagel Latest Developments
13.11 Bio-Rad
13.11.1 Bio-Rad Company Information
13.11.2 Bio-Rad Blood & Tissue DNA Kit Product Portfolios and Specifications
13.11.3 Bio-Rad Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Bio-Rad Main Business Overview
13.11.5 Bio-Rad Latest Developments
13.12 Omega Bio-tek
13.12.1 Omega Bio-tek Company Information
13.12.2 Omega Bio-tek Blood & Tissue DNA Kit Product Portfolios and Specifications
13.12.3 Omega Bio-tek Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Omega Bio-tek Main Business Overview
13.12.5 Omega Bio-tek Latest Developments
13.13 Geneaid
13.13.1 Geneaid Company Information
13.13.2 Geneaid Blood & Tissue DNA Kit Product Portfolios and Specifications
13.13.3 Geneaid Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Geneaid Main Business Overview
13.13.5 Geneaid Latest Developments
13.14 Lucigen (Biosearch Technologies)
13.14.1 Lucigen (Biosearch Technologies) Company Information
13.14.2 Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Product Portfolios and Specifications
13.14.3 Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Lucigen (Biosearch Technologies) Main Business Overview
13.14.5 Lucigen (Biosearch Technologies) Latest Developments
13.15 Norgen
13.15.1 Norgen Company Information
13.15.2 Norgen Blood & Tissue DNA Kit Product Portfolios and Specifications
13.15.3 Norgen Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Norgen Main Business Overview
13.15.5 Norgen Latest Developments
13.16 MGI Tech Co., Ltd.
13.16.1 MGI Tech Co., Ltd. Company Information
13.16.2 MGI Tech Co., Ltd. Blood & Tissue DNA Kit Product Portfolios and Specifications
13.16.3 MGI Tech Co., Ltd. Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 MGI Tech Co., Ltd. Main Business Overview
13.16.5 MGI Tech Co., Ltd. Latest Developments
13.17 BioVision
13.17.1 BioVision Company Information
13.17.2 BioVision Blood & Tissue DNA Kit Product Portfolios and Specifications
13.17.3 BioVision Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 BioVision Main Business Overview
13.17.5 BioVision Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood & Tissue DNA Kit Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood & Tissue DNA Kit by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood & Tissue DNA Kit by Country/Region, 2021, 2025 & 2032
2.2 Blood & Tissue DNA Kit Segment by Type
2.2.1 Whole Blood
2.2.2 Plasma or Serum
2.2.3 Buffy Coat
2.2.4 Blood & Tissue DNA Kit Sales by Type
2.2.4.1 Global Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
2.2.4.2 Global Blood & Tissue DNA Kit Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Blood & Tissue DNA Kit Sale Price by Type (2021-2026)
2.3 Blood & Tissue DNA Kit Segment by Technology
2.3.1 Spin Column-based DNA Kit
2.3.2 Magnetic Bead-based DNA Kit
2.3.3 Precipitation-based DNA Kit
2.3.4 Blood & Tissue DNA Kit Sales by Technology
2.3.4.1 Global Blood & Tissue DNA Kit Sales Market Share by Technology (2021-2026)
2.3.4.2 Global Blood & Tissue DNA Kit Revenue and Market Share by Technology (2021-2026)
2.3.4.3 Global Blood & Tissue DNA Kit Sale Price by Technology (2021-2026)
2.4 Blood & Tissue DNA Kit Segment by Application
2.4.1 R&D Organisations
2.4.2 Biotechnology Companies
2.4.3 Blood & Tissue DNA Kit Sales by Application
2.4.3.1 Global Blood & Tissue DNA Kit Sale Market Share by Application (2021-2026)
2.4.3.2 Global Blood & Tissue DNA Kit Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Blood & Tissue DNA Kit Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood & Tissue DNA Kit Breakdown Data by Company
3.1.1 Global Blood & Tissue DNA Kit Annual Sales by Company (2021-2026)
3.1.2 Global Blood & Tissue DNA Kit Sales Market Share by Company (2021-2026)
3.2 Global Blood & Tissue DNA Kit Annual Revenue by Company (2021-2026)
3.2.1 Global Blood & Tissue DNA Kit Revenue by Company (2021-2026)
3.2.2 Global Blood & Tissue DNA Kit Revenue Market Share by Company (2021-2026)
3.3 Global Blood & Tissue DNA Kit Sale Price by Company
3.4 Key Manufacturers Blood & Tissue DNA Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood & Tissue DNA Kit Product Location Distribution
3.4.2 Players Blood & Tissue DNA Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD & TISSUE DNA KIT BY GEOGRAPHIC REGION
4.1 World Historic Blood & Tissue DNA Kit Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood & Tissue DNA Kit Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood & Tissue DNA Kit Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood & Tissue DNA Kit Market Size by Country/Region (2021-2026)
4.2.1 Global Blood & Tissue DNA Kit Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood & Tissue DNA Kit Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood & Tissue DNA Kit Sales Growth
4.4 APAC Blood & Tissue DNA Kit Sales Growth
4.5 Europe Blood & Tissue DNA Kit Sales Growth
4.6 Middle East & Africa Blood & Tissue DNA Kit Sales Growth
5 AMERICAS
5.1 Americas Blood & Tissue DNA Kit Sales by Country
5.1.1 Americas Blood & Tissue DNA Kit Sales by Country (2021-2026)
5.1.2 Americas Blood & Tissue DNA Kit Revenue by Country (2021-2026)
5.2 Americas Blood & Tissue DNA Kit Sales by Type (2021-2026)
5.3 Americas Blood & Tissue DNA Kit Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood & Tissue DNA Kit Sales by Region
6.1.1 APAC Blood & Tissue DNA Kit Sales by Region (2021-2026)
6.1.2 APAC Blood & Tissue DNA Kit Revenue by Region (2021-2026)
6.2 APAC Blood & Tissue DNA Kit Sales by Type (2021-2026)
6.3 APAC Blood & Tissue DNA Kit Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood & Tissue DNA Kit by Country
7.1.1 Europe Blood & Tissue DNA Kit Sales by Country (2021-2026)
7.1.2 Europe Blood & Tissue DNA Kit Revenue by Country (2021-2026)
7.2 Europe Blood & Tissue DNA Kit Sales by Type (2021-2026)
7.3 Europe Blood & Tissue DNA Kit Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood & Tissue DNA Kit by Country
8.1.1 Middle East & Africa Blood & Tissue DNA Kit Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood & Tissue DNA Kit Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood & Tissue DNA Kit Sales by Type (2021-2026)
8.3 Middle East & Africa Blood & Tissue DNA Kit Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood & Tissue DNA Kit
10.3 Manufacturing Process Analysis of Blood & Tissue DNA Kit
10.4 Industry Chain Structure of Blood & Tissue DNA Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood & Tissue DNA Kit Distributors
11.3 Blood & Tissue DNA Kit Customer
12 WORLD FORECAST REVIEW FOR BLOOD & TISSUE DNA KIT BY GEOGRAPHIC REGION
12.1 Global Blood & Tissue DNA Kit Market Size Forecast by Region
12.1.1 Global Blood & Tissue DNA Kit Forecast by Region (2027-2032)
12.1.2 Global Blood & Tissue DNA Kit Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood & Tissue DNA Kit Forecast by Type (2027-2032)
12.7 Global Blood & Tissue DNA Kit Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 QIAGEN
13.1.1 QIAGEN Company Information
13.1.2 QIAGEN Blood & Tissue DNA Kit Product Portfolios and Specifications
13.1.3 QIAGEN Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 QIAGEN Main Business Overview
13.1.5 QIAGEN Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Blood & Tissue DNA Kit Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Sigma-Aldrich (Merck)
13.3.1 Sigma-Aldrich (Merck) Company Information
13.3.2 Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Product Portfolios and Specifications
13.3.3 Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sigma-Aldrich (Merck) Main Business Overview
13.3.5 Sigma-Aldrich (Merck) Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Blood & Tissue DNA Kit Product Portfolios and Specifications
13.4.3 Roche Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Axygen (Corning)
13.5.1 Axygen (Corning) Company Information
13.5.2 Axygen (Corning) Blood & Tissue DNA Kit Product Portfolios and Specifications
13.5.3 Axygen (Corning) Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Axygen (Corning) Main Business Overview
13.5.5 Axygen (Corning) Latest Developments
13.6 Analytik Jena
13.6.1 Analytik Jena Company Information
13.6.2 Analytik Jena Blood & Tissue DNA Kit Product Portfolios and Specifications
13.6.3 Analytik Jena Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Analytik Jena Main Business Overview
13.6.5 Analytik Jena Latest Developments
13.7 Promega
13.7.1 Promega Company Information
13.7.2 Promega Blood & Tissue DNA Kit Product Portfolios and Specifications
13.7.3 Promega Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Promega Main Business Overview
13.7.5 Promega Latest Developments
13.8 Zymo Research
13.8.1 Zymo Research Company Information
13.8.2 Zymo Research Blood & Tissue DNA Kit Product Portfolios and Specifications
13.8.3 Zymo Research Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zymo Research Main Business Overview
13.8.5 Zymo Research Latest Developments
13.9 Illumina
13.9.1 Illumina Company Information
13.9.2 Illumina Blood & Tissue DNA Kit Product Portfolios and Specifications
13.9.3 Illumina Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Illumina Main Business Overview
13.9.5 Illumina Latest Developments
13.10 Macherey-Nagel
13.10.1 Macherey-Nagel Company Information
13.10.2 Macherey-Nagel Blood & Tissue DNA Kit Product Portfolios and Specifications
13.10.3 Macherey-Nagel Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Macherey-Nagel Main Business Overview
13.10.5 Macherey-Nagel Latest Developments
13.11 Bio-Rad
13.11.1 Bio-Rad Company Information
13.11.2 Bio-Rad Blood & Tissue DNA Kit Product Portfolios and Specifications
13.11.3 Bio-Rad Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Bio-Rad Main Business Overview
13.11.5 Bio-Rad Latest Developments
13.12 Omega Bio-tek
13.12.1 Omega Bio-tek Company Information
13.12.2 Omega Bio-tek Blood & Tissue DNA Kit Product Portfolios and Specifications
13.12.3 Omega Bio-tek Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Omega Bio-tek Main Business Overview
13.12.5 Omega Bio-tek Latest Developments
13.13 Geneaid
13.13.1 Geneaid Company Information
13.13.2 Geneaid Blood & Tissue DNA Kit Product Portfolios and Specifications
13.13.3 Geneaid Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Geneaid Main Business Overview
13.13.5 Geneaid Latest Developments
13.14 Lucigen (Biosearch Technologies)
13.14.1 Lucigen (Biosearch Technologies) Company Information
13.14.2 Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Product Portfolios and Specifications
13.14.3 Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Lucigen (Biosearch Technologies) Main Business Overview
13.14.5 Lucigen (Biosearch Technologies) Latest Developments
13.15 Norgen
13.15.1 Norgen Company Information
13.15.2 Norgen Blood & Tissue DNA Kit Product Portfolios and Specifications
13.15.3 Norgen Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Norgen Main Business Overview
13.15.5 Norgen Latest Developments
13.16 MGI Tech Co., Ltd.
13.16.1 MGI Tech Co., Ltd. Company Information
13.16.2 MGI Tech Co., Ltd. Blood & Tissue DNA Kit Product Portfolios and Specifications
13.16.3 MGI Tech Co., Ltd. Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 MGI Tech Co., Ltd. Main Business Overview
13.16.5 MGI Tech Co., Ltd. Latest Developments
13.17 BioVision
13.17.1 BioVision Company Information
13.17.2 BioVision Blood & Tissue DNA Kit Product Portfolios and Specifications
13.17.3 BioVision Blood & Tissue DNA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 BioVision Main Business Overview
13.17.5 BioVision Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood & Tissue DNA Kit Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood & Tissue DNA Kit Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Whole Blood
Table 4. Major Players of Plasma or Serum
Table 5. Major Players of Buffy Coat
Table 6. Global Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 7. Global Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Table 8. Global Blood & Tissue DNA Kit Revenue by Type (2021-2026) & ($ million)
Table 9. Global Blood & Tissue DNA Kit Revenue Market Share by Type (2021-2026)
Table 10. Global Blood & Tissue DNA Kit Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Spin Column-based DNA Kit
Table 12. Major Players of Magnetic Bead-based DNA Kit
Table 13. Major Players of Precipitation-based DNA Kit
Table 14. Global Blood & Tissue DNA Kit Sales by Technology (2021-2026) & (K Units)
Table 15. Global Blood & Tissue DNA Kit Sales Market Share by Technology (2021-2026)
Table 16. Global Blood & Tissue DNA Kit Revenue by Technology (2021-2026) & ($ million)
Table 17. Global Blood & Tissue DNA Kit Revenue Market Share by Technology (2021-2026)
Table 18. Global Blood & Tissue DNA Kit Sale Price by Technology (2021-2026) & (US$/Unit)
Table 19. Global Blood & Tissue DNA Kit Sale by Application (2021-2026) & (K Units)
Table 20. Global Blood & Tissue DNA Kit Sale Market Share by Application (2021-2026)
Table 21. Global Blood & Tissue DNA Kit Revenue by Application (2021-2026) & ($ million)
Table 22. Global Blood & Tissue DNA Kit Revenue Market Share by Application (2021-2026)
Table 23. Global Blood & Tissue DNA Kit Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Blood & Tissue DNA Kit Sales by Company (2021-2026) & (K Units)
Table 25. Global Blood & Tissue DNA Kit Sales Market Share by Company (2021-2026)
Table 26. Global Blood & Tissue DNA Kit Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Blood & Tissue DNA Kit Revenue Market Share by Company (2021-2026)
Table 28. Global Blood & Tissue DNA Kit Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Blood & Tissue DNA Kit Producing Area Distribution and Sales Area
Table 30. Players Blood & Tissue DNA Kit Products Offered
Table 31. Blood & Tissue DNA Kit Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Blood & Tissue DNA Kit Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Blood & Tissue DNA Kit Sales Market Share Geographic Region (2021-2026)
Table 36. Global Blood & Tissue DNA Kit Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Blood & Tissue DNA Kit Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Blood & Tissue DNA Kit Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Blood & Tissue DNA Kit Sales Market Share by Country/Region (2021-2026)
Table 40. Global Blood & Tissue DNA Kit Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Blood & Tissue DNA Kit Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Blood & Tissue DNA Kit Sales by Country (2021-2026) & (K Units)
Table 43. Americas Blood & Tissue DNA Kit Sales Market Share by Country (2021-2026)
Table 44. Americas Blood & Tissue DNA Kit Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 46. Americas Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 47. APAC Blood & Tissue DNA Kit Sales by Region (2021-2026) & (K Units)
Table 48. APAC Blood & Tissue DNA Kit Sales Market Share by Region (2021-2026)
Table 49. APAC Blood & Tissue DNA Kit Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 51. APAC Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 52. Europe Blood & Tissue DNA Kit Sales by Country (2021-2026) & (K Units)
Table 53. Europe Blood & Tissue DNA Kit Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 55. Europe Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Blood & Tissue DNA Kit Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Blood & Tissue DNA Kit Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Blood & Tissue DNA Kit
Table 61. Key Market Challenges & Risks of Blood & Tissue DNA Kit
Table 62. Key Industry Trends of Blood & Tissue DNA Kit
Table 63. Blood & Tissue DNA Kit Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Blood & Tissue DNA Kit Distributors List
Table 66. Blood & Tissue DNA Kit Customer List
Table 67. Global Blood & Tissue DNA Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Blood & Tissue DNA Kit Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Blood & Tissue DNA Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Blood & Tissue DNA Kit Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Blood & Tissue DNA Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Blood & Tissue DNA Kit Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Blood & Tissue DNA Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Blood & Tissue DNA Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Blood & Tissue DNA Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Blood & Tissue DNA Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Blood & Tissue DNA Kit Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Blood & Tissue DNA Kit Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Blood & Tissue DNA Kit Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Blood & Tissue DNA Kit Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. QIAGEN Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 82. QIAGEN Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 83. QIAGEN Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. QIAGEN Main Business
Table 85. QIAGEN Latest Developments
Table 86. Thermo Fisher Scientific Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 87. Thermo Fisher Scientific Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 88. Thermo Fisher Scientific Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Thermo Fisher Scientific Main Business
Table 90. Thermo Fisher Scientific Latest Developments
Table 91. Sigma-Aldrich (Merck) Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 92. Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 93. Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Sigma-Aldrich (Merck) Main Business
Table 95. Sigma-Aldrich (Merck) Latest Developments
Table 96. Roche Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 98. Roche Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. Axygen (Corning) Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 102. Axygen (Corning) Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 103. Axygen (Corning) Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Axygen (Corning) Main Business
Table 105. Axygen (Corning) Latest Developments
Table 106. Analytik Jena Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 107. Analytik Jena Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 108. Analytik Jena Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Analytik Jena Main Business
Table 110. Analytik Jena Latest Developments
Table 111. Promega Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 112. Promega Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 113. Promega Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Promega Main Business
Table 115. Promega Latest Developments
Table 116. Zymo Research Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 117. Zymo Research Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 118. Zymo Research Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Zymo Research Main Business
Table 120. Zymo Research Latest Developments
Table 121. Illumina Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 122. Illumina Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 123. Illumina Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Illumina Main Business
Table 125. Illumina Latest Developments
Table 126. Macherey-Nagel Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 127. Macherey-Nagel Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 128. Macherey-Nagel Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Macherey-Nagel Main Business
Table 130. Macherey-Nagel Latest Developments
Table 131. Bio-Rad Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 132. Bio-Rad Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 133. Bio-Rad Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Bio-Rad Main Business
Table 135. Bio-Rad Latest Developments
Table 136. Omega Bio-tek Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 137. Omega Bio-tek Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 138. Omega Bio-tek Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Omega Bio-tek Main Business
Table 140. Omega Bio-tek Latest Developments
Table 141. Geneaid Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 142. Geneaid Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 143. Geneaid Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Geneaid Main Business
Table 145. Geneaid Latest Developments
Table 146. Lucigen (Biosearch Technologies) Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 147. Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 148. Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Lucigen (Biosearch Technologies) Main Business
Table 150. Lucigen (Biosearch Technologies) Latest Developments
Table 151. Norgen Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 152. Norgen Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 153. Norgen Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Norgen Main Business
Table 155. Norgen Latest Developments
Table 156. MGI Tech Co., Ltd. Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 157. MGI Tech Co., Ltd. Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 158. MGI Tech Co., Ltd. Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. MGI Tech Co., Ltd. Main Business
Table 160. MGI Tech Co., Ltd. Latest Developments
Table 161. BioVision Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 162. BioVision Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 163. BioVision Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. BioVision Main Business
Table 165. BioVision Latest Developments
Table 1. Blood & Tissue DNA Kit Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood & Tissue DNA Kit Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Whole Blood
Table 4. Major Players of Plasma or Serum
Table 5. Major Players of Buffy Coat
Table 6. Global Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 7. Global Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Table 8. Global Blood & Tissue DNA Kit Revenue by Type (2021-2026) & ($ million)
Table 9. Global Blood & Tissue DNA Kit Revenue Market Share by Type (2021-2026)
Table 10. Global Blood & Tissue DNA Kit Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Spin Column-based DNA Kit
Table 12. Major Players of Magnetic Bead-based DNA Kit
Table 13. Major Players of Precipitation-based DNA Kit
Table 14. Global Blood & Tissue DNA Kit Sales by Technology (2021-2026) & (K Units)
Table 15. Global Blood & Tissue DNA Kit Sales Market Share by Technology (2021-2026)
Table 16. Global Blood & Tissue DNA Kit Revenue by Technology (2021-2026) & ($ million)
Table 17. Global Blood & Tissue DNA Kit Revenue Market Share by Technology (2021-2026)
Table 18. Global Blood & Tissue DNA Kit Sale Price by Technology (2021-2026) & (US$/Unit)
Table 19. Global Blood & Tissue DNA Kit Sale by Application (2021-2026) & (K Units)
Table 20. Global Blood & Tissue DNA Kit Sale Market Share by Application (2021-2026)
Table 21. Global Blood & Tissue DNA Kit Revenue by Application (2021-2026) & ($ million)
Table 22. Global Blood & Tissue DNA Kit Revenue Market Share by Application (2021-2026)
Table 23. Global Blood & Tissue DNA Kit Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Blood & Tissue DNA Kit Sales by Company (2021-2026) & (K Units)
Table 25. Global Blood & Tissue DNA Kit Sales Market Share by Company (2021-2026)
Table 26. Global Blood & Tissue DNA Kit Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Blood & Tissue DNA Kit Revenue Market Share by Company (2021-2026)
Table 28. Global Blood & Tissue DNA Kit Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Blood & Tissue DNA Kit Producing Area Distribution and Sales Area
Table 30. Players Blood & Tissue DNA Kit Products Offered
Table 31. Blood & Tissue DNA Kit Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Blood & Tissue DNA Kit Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Blood & Tissue DNA Kit Sales Market Share Geographic Region (2021-2026)
Table 36. Global Blood & Tissue DNA Kit Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Blood & Tissue DNA Kit Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Blood & Tissue DNA Kit Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Blood & Tissue DNA Kit Sales Market Share by Country/Region (2021-2026)
Table 40. Global Blood & Tissue DNA Kit Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Blood & Tissue DNA Kit Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Blood & Tissue DNA Kit Sales by Country (2021-2026) & (K Units)
Table 43. Americas Blood & Tissue DNA Kit Sales Market Share by Country (2021-2026)
Table 44. Americas Blood & Tissue DNA Kit Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 46. Americas Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 47. APAC Blood & Tissue DNA Kit Sales by Region (2021-2026) & (K Units)
Table 48. APAC Blood & Tissue DNA Kit Sales Market Share by Region (2021-2026)
Table 49. APAC Blood & Tissue DNA Kit Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 51. APAC Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 52. Europe Blood & Tissue DNA Kit Sales by Country (2021-2026) & (K Units)
Table 53. Europe Blood & Tissue DNA Kit Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 55. Europe Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Blood & Tissue DNA Kit Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Blood & Tissue DNA Kit Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Blood & Tissue DNA Kit Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Blood & Tissue DNA Kit Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Blood & Tissue DNA Kit
Table 61. Key Market Challenges & Risks of Blood & Tissue DNA Kit
Table 62. Key Industry Trends of Blood & Tissue DNA Kit
Table 63. Blood & Tissue DNA Kit Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Blood & Tissue DNA Kit Distributors List
Table 66. Blood & Tissue DNA Kit Customer List
Table 67. Global Blood & Tissue DNA Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Blood & Tissue DNA Kit Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Blood & Tissue DNA Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Blood & Tissue DNA Kit Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Blood & Tissue DNA Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Blood & Tissue DNA Kit Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Blood & Tissue DNA Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Blood & Tissue DNA Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Blood & Tissue DNA Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Blood & Tissue DNA Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Blood & Tissue DNA Kit Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Blood & Tissue DNA Kit Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Blood & Tissue DNA Kit Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Blood & Tissue DNA Kit Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. QIAGEN Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 82. QIAGEN Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 83. QIAGEN Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. QIAGEN Main Business
Table 85. QIAGEN Latest Developments
Table 86. Thermo Fisher Scientific Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 87. Thermo Fisher Scientific Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 88. Thermo Fisher Scientific Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Thermo Fisher Scientific Main Business
Table 90. Thermo Fisher Scientific Latest Developments
Table 91. Sigma-Aldrich (Merck) Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 92. Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 93. Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Sigma-Aldrich (Merck) Main Business
Table 95. Sigma-Aldrich (Merck) Latest Developments
Table 96. Roche Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 98. Roche Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. Axygen (Corning) Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 102. Axygen (Corning) Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 103. Axygen (Corning) Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Axygen (Corning) Main Business
Table 105. Axygen (Corning) Latest Developments
Table 106. Analytik Jena Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 107. Analytik Jena Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 108. Analytik Jena Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Analytik Jena Main Business
Table 110. Analytik Jena Latest Developments
Table 111. Promega Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 112. Promega Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 113. Promega Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Promega Main Business
Table 115. Promega Latest Developments
Table 116. Zymo Research Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 117. Zymo Research Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 118. Zymo Research Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Zymo Research Main Business
Table 120. Zymo Research Latest Developments
Table 121. Illumina Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 122. Illumina Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 123. Illumina Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Illumina Main Business
Table 125. Illumina Latest Developments
Table 126. Macherey-Nagel Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 127. Macherey-Nagel Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 128. Macherey-Nagel Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Macherey-Nagel Main Business
Table 130. Macherey-Nagel Latest Developments
Table 131. Bio-Rad Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 132. Bio-Rad Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 133. Bio-Rad Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Bio-Rad Main Business
Table 135. Bio-Rad Latest Developments
Table 136. Omega Bio-tek Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 137. Omega Bio-tek Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 138. Omega Bio-tek Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Omega Bio-tek Main Business
Table 140. Omega Bio-tek Latest Developments
Table 141. Geneaid Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 142. Geneaid Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 143. Geneaid Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Geneaid Main Business
Table 145. Geneaid Latest Developments
Table 146. Lucigen (Biosearch Technologies) Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 147. Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 148. Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Lucigen (Biosearch Technologies) Main Business
Table 150. Lucigen (Biosearch Technologies) Latest Developments
Table 151. Norgen Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 152. Norgen Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 153. Norgen Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Norgen Main Business
Table 155. Norgen Latest Developments
Table 156. MGI Tech Co., Ltd. Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 157. MGI Tech Co., Ltd. Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 158. MGI Tech Co., Ltd. Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. MGI Tech Co., Ltd. Main Business
Table 160. MGI Tech Co., Ltd. Latest Developments
Table 161. BioVision Basic Information, Blood & Tissue DNA Kit Manufacturing Base, Sales Area and Its Competitors
Table 162. BioVision Blood & Tissue DNA Kit Product Portfolios and Specifications
Table 163. BioVision Blood & Tissue DNA Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. BioVision Main Business
Table 165. BioVision Latest Developments
LIST OF FIGURES
Figure 1. Picture of Blood & Tissue DNA Kit
Figure 2. Blood & Tissue DNA Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood & Tissue DNA Kit Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Blood & Tissue DNA Kit Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood & Tissue DNA Kit Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood & Tissue DNA Kit Sales Market Share by Country/Region (2025)
Figure 10. Blood & Tissue DNA Kit Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Whole Blood
Figure 12. Product Picture of Plasma or Serum
Figure 13. Product Picture of Buffy Coat
Figure 14. Global Blood & Tissue DNA Kit Sales Market Share by Type in 2026
Figure 15. Global Blood & Tissue DNA Kit Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Spin Column-based DNA Kit
Figure 17. Product Picture of Magnetic Bead-based DNA Kit
Figure 18. Product Picture of Precipitation-based DNA Kit
Figure 19. Global Blood & Tissue DNA Kit Sales Market Share by Technology in 2026
Figure 20. Global Blood & Tissue DNA Kit Revenue Market Share by Technology (2021-2026)
Figure 21. Blood & Tissue DNA Kit Consumed in R&D Organisations
Figure 22. Global Blood & Tissue DNA Kit Market: R&D Organisations (2021-2026) & (K Units)
Figure 23. Blood & Tissue DNA Kit Consumed in Biotechnology Companies
Figure 24. Global Blood & Tissue DNA Kit Market: Biotechnology Companies (2021-2026) & (K Units)
Figure 25. Global Blood & Tissue DNA Kit Sale Market Share by Application (2025)
Figure 26. Global Blood & Tissue DNA Kit Revenue Market Share by Application in 2026
Figure 27. Blood & Tissue DNA Kit Sales by Company in 2026 (K Units)
Figure 28. Global Blood & Tissue DNA Kit Sales Market Share by Company in 2026
Figure 29. Blood & Tissue DNA Kit Revenue by Company in 2026 ($ millions)
Figure 30. Global Blood & Tissue DNA Kit Revenue Market Share by Company in 2026
Figure 31. Global Blood & Tissue DNA Kit Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Blood & Tissue DNA Kit Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 34. Americas Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 35. APAC Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 36. APAC Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 37. Europe Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 38. Europe Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 41. Americas Blood & Tissue DNA Kit Sales Market Share by Country in 2026
Figure 42. Americas Blood & Tissue DNA Kit Revenue Market Share by Country (2021-2026)
Figure 43. Americas Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 44. Americas Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 45. United States Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Blood & Tissue DNA Kit Sales Market Share by Region in 2026
Figure 50. APAC Blood & Tissue DNA Kit Revenue Market Share by Region (2021-2026)
Figure 51. APAC Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 52. APAC Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 53. China Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 57. India Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Blood & Tissue DNA Kit Sales Market Share by Country in 2026
Figure 61. Europe Blood & Tissue DNA Kit Revenue Market Share by Country (2021-2026)
Figure 62. Europe Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 63. Europe Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 64. Germany Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 65. France Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Blood & Tissue DNA Kit Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 72. Egypt Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Blood & Tissue DNA Kit in 2026
Figure 78. Manufacturing Process Analysis of Blood & Tissue DNA Kit
Figure 79. Industry Chain Structure of Blood & Tissue DNA Kit
Figure 80. Channels of Distribution
Figure 81. Global Blood & Tissue DNA Kit Sales Market Forecast by Region (2027-2032)
Figure 82. Global Blood & Tissue DNA Kit Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Blood & Tissue DNA Kit Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Blood & Tissue DNA Kit Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Blood & Tissue DNA Kit Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Blood & Tissue DNA Kit Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Blood & Tissue DNA Kit
Figure 2. Blood & Tissue DNA Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood & Tissue DNA Kit Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Blood & Tissue DNA Kit Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood & Tissue DNA Kit Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood & Tissue DNA Kit Sales Market Share by Country/Region (2025)
Figure 10. Blood & Tissue DNA Kit Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Whole Blood
Figure 12. Product Picture of Plasma or Serum
Figure 13. Product Picture of Buffy Coat
Figure 14. Global Blood & Tissue DNA Kit Sales Market Share by Type in 2026
Figure 15. Global Blood & Tissue DNA Kit Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Spin Column-based DNA Kit
Figure 17. Product Picture of Magnetic Bead-based DNA Kit
Figure 18. Product Picture of Precipitation-based DNA Kit
Figure 19. Global Blood & Tissue DNA Kit Sales Market Share by Technology in 2026
Figure 20. Global Blood & Tissue DNA Kit Revenue Market Share by Technology (2021-2026)
Figure 21. Blood & Tissue DNA Kit Consumed in R&D Organisations
Figure 22. Global Blood & Tissue DNA Kit Market: R&D Organisations (2021-2026) & (K Units)
Figure 23. Blood & Tissue DNA Kit Consumed in Biotechnology Companies
Figure 24. Global Blood & Tissue DNA Kit Market: Biotechnology Companies (2021-2026) & (K Units)
Figure 25. Global Blood & Tissue DNA Kit Sale Market Share by Application (2025)
Figure 26. Global Blood & Tissue DNA Kit Revenue Market Share by Application in 2026
Figure 27. Blood & Tissue DNA Kit Sales by Company in 2026 (K Units)
Figure 28. Global Blood & Tissue DNA Kit Sales Market Share by Company in 2026
Figure 29. Blood & Tissue DNA Kit Revenue by Company in 2026 ($ millions)
Figure 30. Global Blood & Tissue DNA Kit Revenue Market Share by Company in 2026
Figure 31. Global Blood & Tissue DNA Kit Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Blood & Tissue DNA Kit Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 34. Americas Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 35. APAC Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 36. APAC Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 37. Europe Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 38. Europe Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Blood & Tissue DNA Kit Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Blood & Tissue DNA Kit Revenue 2021-2026 ($ millions)
Figure 41. Americas Blood & Tissue DNA Kit Sales Market Share by Country in 2026
Figure 42. Americas Blood & Tissue DNA Kit Revenue Market Share by Country (2021-2026)
Figure 43. Americas Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 44. Americas Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 45. United States Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Blood & Tissue DNA Kit Sales Market Share by Region in 2026
Figure 50. APAC Blood & Tissue DNA Kit Revenue Market Share by Region (2021-2026)
Figure 51. APAC Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 52. APAC Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 53. China Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 57. India Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Blood & Tissue DNA Kit Sales Market Share by Country in 2026
Figure 61. Europe Blood & Tissue DNA Kit Revenue Market Share by Country (2021-2026)
Figure 62. Europe Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 63. Europe Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 64. Germany Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 65. France Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Blood & Tissue DNA Kit Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Blood & Tissue DNA Kit Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Blood & Tissue DNA Kit Sales Market Share by Application (2021-2026)
Figure 72. Egypt Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Blood & Tissue DNA Kit Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Blood & Tissue DNA Kit in 2026
Figure 78. Manufacturing Process Analysis of Blood & Tissue DNA Kit
Figure 79. Industry Chain Structure of Blood & Tissue DNA Kit
Figure 80. Channels of Distribution
Figure 81. Global Blood & Tissue DNA Kit Sales Market Forecast by Region (2027-2032)
Figure 82. Global Blood & Tissue DNA Kit Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Blood & Tissue DNA Kit Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Blood & Tissue DNA Kit Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Blood & Tissue DNA Kit Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Blood & Tissue DNA Kit Revenue Market Share Forecast by Application (2027-2032)
